Download the App!
show episodes
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
  continue reading
 
From Idea to Action: Stories from Alabama Innovators is a podcast that highlights the people who are driving Alabama forward. We aim to showcase and connect the deep network of innovators, entrepreneurs, policy leaders, and advocates working to make Alabama an even better place. From Idea to Action: Stories from Alabama Innovators is powered by the HudsonAlpha Institute for Biotechnology, a nonprofit organization with a mission to improve the human condition.
  continue reading
 
Artwork
 
Podcasts from KTH Royal Institute of Technology, Stockholm, Sweden. Interviews on research and innovations from KTH, sometimes with KTH:s partners. Podcasts are produced by the Communications Department at KTH. KTH Royal Institute of Technology in Stockholm, Sweden, is the largest and oldest technical university in Sweden. No less than one third of Sweden’s technical research and engineering education capacity at university level is provided by KTH. Education and research spans from natural ...
  continue reading
 
Loading …
show series
 
This week on Data in Biotech, we’re delighted to be joined by Guru and Satya Singh, co-founders of SciSpot, a company focused on transforming biotech companies through smarter embodiment of biological processes in data/software and acceleration of the R&D process. They discuss how their respective biotech and data backgrounds led them to develop th…
  continue reading
 
This week, Ross sits down with Mike Nally, CEO at Generate:Biomedicines, a pioneer in generative biology that is transforming the way medicines are developed. Mike joined the Data in Biotech podcast to discuss the AI-driven drug development landscape and how data is set to change the way every drug is made in the future. Mike shares his journey to …
  continue reading
 
This week, Nathan Clark, CEO at Ganymede, joins the Data in Biotech podcast to discuss the challenges of integrating lab instruments and data in the biotech industry and how Ganymede’s developer platform is helping to automate data integration and metadata management across Life Sciences. Nathan sits down with Data in Biotech host Ross Katz to disc…
  continue reading
 
This week, Harshil Patel, Director of Scientific Development at Seqera, joins the Data in Biotech podcast to discuss the importance of collaborative, open-source projects in scientific research and how they support the need for reproducibility. Harshil lifts the lid on how Nextflow has become a leading open-source workflow management tool for scien…
  continue reading
 
YOU asked, and we answered. In this episode, we had our experts on standby to answer questions from you, our listeners. We discuss topics ranging from the safety of genetically modified foods (GMOs), to the new era of personalized medicine, feeding the world by 2050, and even what makes start-up companies attractive to investors. Follow us on Linke…
  continue reading
 
This week, we are pleased to have Stewart Fossceco, Head of Non-Clinical and Diagnostics Statistics at Zoetis and an expert in pharmaceutical manufacturing, join us on the Data in Biotech podcast. We sat down with Stewart to discuss implementing and improving Quality Assurance (QA) processes at every stage of biotech manufacturing, from optimizing …
  continue reading
 
With its potential to expand the horizons of what’s possible for patients, CRISPR is the new darling of biotech. Reaching an important milestone in 2023 with the FDA approval of a sickle cell treatment using CRISPR, the technology is poised to break new barriers for treating patients in the near future. In this episode we talk with two companies wo…
  continue reading
 
This week, we are pleased to welcome to the Data in Biotech podcast Brendan McCorkle, CEO of SciNote, a cloud-based ELN (Electronic Lab Notebook) with lab inventory, compliance, and team management tools. In this episode, we discuss how the priorities of ‘Research’ and ‘Development’ differ when it comes to the data they expect and how they use it, …
  continue reading
 
Biotech companies are addressing climate change through innovation—from carbon neutral facilities to agricultural innovations to reduce greenhouse gas emissions. BIO was on the ground at the COP28 UN Climate Change Conference in Dubai to deliver the message that biotech is climate tech. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at …
  continue reading
 
This week, we are pleased to be joined on the Data in Biotech Podcast by Pierre Salvy, who recently became the CTO at Cambrium, and his colleague Lucile Bonnin, Head of Research & Development at Cambrium. As part of the Cambrium team behind NovaColl™, the first micro-molecular and skin-identical vegan collagen to market, Pierre and Lucile share the…
  continue reading
 
More than half of U.S. households include pets, but there has been a lack of medical treatments developed specifically for small animals. Biotech companies are working to change that with new treatment options that both borrow from and, potentially, advance human health discoveries. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at http…
  continue reading
 
This week, we are pleased to welcome Jacob Oppenheim, Entrepreneur in Residence at Digitalis Ventures, a venture capital firm that invests in solutions to complex problems in human and animal health. Jacob sat down with Ross to discuss the importance of establishing strong data foundations in biotech companies and how to approach the task. We explo…
  continue reading
 
The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don’t. Two companies, Bloom Science and Seres Therapeutics, a…
  continue reading
 
This week's guest is Joseph Pearson, Global Product Manager of OmicSoft at QIAGEN, a global provider of sample-to-insight solutions that enable customers to gain valuable molecular insights. During this episode, we dive into OmicSoft, a powerful NGS analysis suite that can quickly explore and compare 500,000 curated omics samples from disease-relat…
  continue reading
 
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocate…
  continue reading
 
This week's guest is Wolfgang Halter, Head of Data Science and Bioinformatics at Merck Life Science, a leading global science and technology company. Ross sat down with Wolfgang to discuss the work on the BayBE project, an open-source library built for Bayesian optimization. Throughout the episode, we go on to learn how BayBE is used for both exper…
  continue reading
 
Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to mad scientist, to biotech comp…
  continue reading
 
This week, we’re delighted to be joined by Annemie Ribbens, VP Science, Evidence and Trials at icometrix, a medical technology manufacturer that offers a portfolio of AI solutions to assist healthcare with various challenges in neurological disorders, such as brain trauma, strokes, dementia, and Alzheimer's disease. During this episode, Annemie ope…
  continue reading
 
Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we’ve entered a synbio revolution, and it holds potential to improve the health of people and our planet. In this episode, we talk with …
  continue reading
 
This week, we’re delighted to be joined by Lana Denysyk, Head of RWD Assets at Novo Nordisk. During this conversation, Lana shares how real-world data is used in biotech, diving into how it can help clinicians understand patient experiences outside clinical trials. Lana also discusses the challenges in acquiring and utilising real-world data, the i…
  continue reading
 
For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges face…
  continue reading
 
This week, we’re delighted to be joined by Cody Schiffer, Associate Director, Machine Learning at SMPA - a biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need, During this conversation, Cody and Ross discuss the construction, maintenance, and application of a knowledge graphic i…
  continue reading
 
The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests speak to why women’s leadership matters and the barriers…
  continue reading
 
This week, we’re delighted to be joined by Vera Mucaj, Chief Scientific Officer at Datavant, a data logistics company for healthcare. During the interview, Vera shares how the organization helps companies overcome issues of data fragmentation and availability, which ultimately leads to better decision-making in healthcare, the importance of connect…
  continue reading
 
Bees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That’s why reports of a decline in bee populations and rising threats from pests, viruses and environmental pressures, including climate change, are alarming. In this episode we talk with an expert on bees a…
  continue reading
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences. This week, we’re delighted to be joined by James Winegar, CEO of CorrDyn, a data-driven technology consultancy that helps some of the largest biotechnology manufacturers in the US make smarter strategic decisions by unlocking the value of the…
  continue reading
 
The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading bacteria, thereby protecting them from the attacking to…
  continue reading
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences. This week, we’re delighted to be joined by Harry Rickerby, Co-founder of Briefly Bio, a groundbreaking platform he's developing to streamline experimental design in life sciences using large language models (LLMs). Host Ross Katz speaks with …
  continue reading
 
Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to "mad scientist" to biotech com…
  continue reading
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences. This week, we’re delighted to be joined by Jesse Johnson, Founder of Merelogic, a consultancy service for biotech startups who want to get their data under control so they can focus on the science. Host Ross Katz speaks with Jesse about the i…
  continue reading
 
This episode features Bill Poole, Finance Director for the State of Alabama, and Cynthia Crutchfield, CEO of Innovate Alabama. These two Alabama leaders discuss how the State and Innovate Alabama support entrepreneurs, businesses, and commercialization. They share about the history of the Innovation Commission that kicked off new resources for Alab…
  continue reading
 
Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we’ve entered a synbio revolution, and it holds poten…
  continue reading
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. This week, we're delighted to be joined by Tommy Tang, Director of Computational Biology at Immunitas Therapeutics - an immuno-oncology therapeutics company advancing multiple programs to the clinic. Host Ross Katz speaks with Ming “…
  continue reading
 
In this episode, we sit down with Todd Greer, Executive Director of Innovation Portal, a nonprofit incubator and innovation hub accelerating startup growth in the Gulf Coast Region. We discuss how to support small businesses and what it takes to nurture economic growth and draw similarities between Mobile and the other major cities across Alabama. …
  continue reading
 
Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the imm…
  continue reading
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. This week, we're delighted to be joined by Miguel Cacho Soblechero, Ph.D., a senior data scientist at Prolaio - a biotech company that integrates clinical research and data science to improve research, access and outcomes for people …
  continue reading
 
Description: In this episode, we sit down to talk with Sean Powers, PhD, Angelia and Steven Stokes Endowed Professor in Environmental Resiliency and Director, Stokes School of Marine Sciences, University of South Alabama. Over the course of this episode, we talk about his journey to Alabama and how Gulf Coast research and global fishery research in…
  continue reading
 
Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led compan…
  continue reading
 
In this episode, we sit down to talk with Jo Bonner, President of the University of South Alabama in Mobile, AL. We discuss President Bonner’s unique background and his goal to leverage South Alabama’s unique environment to attract talent, carve out a unique space in the academic landscape, and make a profound impact on the state and beyond. Dig in…
  continue reading
 
This week, we're delighted to be joined by Michelle Wiest, Director of IVD Biostatistics at Freenome - a high-growth biotech company that creates tools to help prevent, detect, and treat disease. Host Ross Katz speaks with Michelle on the use of biostatistics in the field of diagnostics, what biases can corrupt diagnostic tests and how to catch the…
  continue reading
 
This week, we're delighted to be joined by Markus Gershater, Chief Scientific Officer and CoFounder of Synthace - a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. Host Ross Katz speaks with Markus on what’s broken about: What’s broken about…
  continue reading
 
This week we’re excited to be joined by Pradeep Ravindra, Associate Director, Data Analytics, Manufacturing from Lyell Immunopharma. He shares his story on transitioning from military intelligence to life sciences analytics, the role of data analytics in manufacturing and delivering CAR-T therapies, and how to foster a culture of data-driven decisi…
  continue reading
 
Welcome to Data in Biotech, a podcast from CorrDyn where we explore how companies leverage data to drive innovation in life sciences. In each episode, our host Ross Katz, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in li…
  continue reading
 
Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ Bees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That’s why reports of a decline in bee populations and rising threats from pests, viruses and environmental pressures, inclu…
  continue reading
 
In this episode, we sit down to talk with Joe Kirgues, co-founder of gener8tor, a venture capital firm out of Wisconsin. Even though he isn’t from Alabama, Joe and gener8tor are invested in success in the “flyover states” that are often overlooked in investment discussions. Take a listen to this episode as we discuss his background and what it mean…
  continue reading
 
Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cell…
  continue reading
 
In this episode, we talk with Jason Green, PhD, Dean of The University of Alabama in Huntsville (UAH) College of Business Administration. We talk about how UAH supports the next generation of the workforce, engages students with the mentality of “practice makes a professional,” and the value of engaging your local community. Dig into more informati…
  continue reading
 
In this episode, we sit down with Charisse Stokes, Executive Director at TECHMGM: an initiative to coordinate the efforts of many diverse partners around developing the tech and innovation ecosystem in Montgomery. We discuss what it means to plant roots in a new community, be comfortable with the uncomfortable, and how progress involves looking to …
  continue reading
 
Wading through the torrent of information available online is challenging for everyone. It can be hard to know what and whom to believe. We talk with the FDA Commissioner and other leaders on the frontlines of health and science about how to be more aware of false and misleading information, and its risks to our wellbeing and future innovation. And…
  continue reading
 
In this episode, we sit down to talk with Jeff Helms and Russ Durrance of the Alabama Farmers Federation. We discuss the history of the Farmers Federation, how ALFA supports agriculture, farmers, and farming innovation in Alabama, and how a combination of grassroots and public-policy work supports farmers. Dig into more information: Jeff Helms http…
  continue reading
 
Loading …

Quick Reference Guide